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ABSTRACT 
Background:  
Although smoking during pregnancy may lead to many adverse outcomes, numerous studies have 
reported a paradoxical inverse association between maternal cigarette smoking during pregnancy and 
preeclampsia. Using a counterfactual framework we aimed to explore the structure of this paradox as 
being a consequence of selection bias.   
Methods:  
Using a case-control study nested in the Icelandic Birth Registry (1,309 women), we show how this 
selection bias can be explored and corrected for. Cases were defined as any case of pregnancy induced 
hypertension or preeclampsia occurring after 20 weeks’ gestation and controls as normotensive 
mothers who gave birth in the same year. First, we used directed acyclic graphs to illustrate the common 
bias structure. Second, we used classical logistic regression and mediation analytic methods for 
dichotomous outcomes to explore the structure of the bias. Lastly, we performed both deterministic and 
probabilistic sensitivity analysis to estimate the amount of bias due to an uncontrolled confounder and 
corrected for it.  
Results:  
The biased effect of smoking was estimated to reduce the odds of preeclampsia by 28% (OR=0.72, 
95%CI: 0.52, 0.99) and after stratification by gestational age at delivery (<37 vs. ≥37 gestation weeks) 
by 75% (OR=0.25, 95%CI: 0.10, 0.68). In a mediation analysis, the natural indirect effect showed and 
OR >1, revealing the structure of the paradox. The bias-adjusted estimation of the smoking effect on 
preeclampsia showed an OR of 1.22 (95%CI: 0.41, 6.53).  
Discussion:  
The smoking-preeclampsia paradox appears to be an example of (1) selection bias most likely caused 
by studying cases prevalent at birth rather than all incident cases from conception in a pregnancy 
cohort, (2) omitting important confounders associated with both smoking and preeclampsia (preventing 
the outcome to develop) and (3) controlling implicitly or explicitly for a collider (gestation weeks at 
delivery). Future studies need to consider these aspects when studying and interpreting the association 
between smoking and pregnancy outcomes.  
 
Keywords: Preeclampsia; Smoking; Selection Bias; Epidemiology Methods; Perinatal Mortality 
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BACKGROUND 
 
Preeclampsia complicates between 2 and 8% of all pregnancies and is a leading cause of maternal and 
infant morbidity and mortality worldwide.1,2 Although smoking during pregnancy may lead to many 
adverse maternal and perinatal outcomes, numerous studies have reported a paradoxical inverse 
association between cigarette smoking during pregnancy and preeclampsia in different populations, 
namely the “smoking-preeclampsia paradox”.3-7 
In the epidemiological literature different explanations have been proposed to describe the paradoxical 
protective effect of established risk factors (e.g., smoking) on an outcome.8-10 Depending on the way 
that the association between a risk factor and an outcome is induced, this paradoxical protective effect 
has been referred to as collider bias, gestational age paradox, incidence-prevalence bias, competing 
risk and Neyman bias11-13 yet these are all special cases of a general type of bias named “selection 
bias”.14 Selection biases leading to paradoxical effects have been described as biases arising from 
inappropriate selection of study subjects from the source population.15  
In the particular case of the smoking-preeclampsia paradox, many studies documenting the inverse 
association used case-control designs with prevalent cases and omitted important factors associated 
with both smoking and preeclampsia (e.g., fetoplacental pathologies associated with preterm 
delivery)3,4,7,16-20. Such unmeasured confounders would make gestational age at delivery a collider. 
Thus, controlling for the collider (gestational age at delivery) will cause the association between smoking 
and preeclampsia to be biased.9,21  
We hypothesized that the smoking-preeclampsia paradox, is an example of selection bias caused by 
(1) studying cases prevalent at birth rather than all incident cases in a conception or pregnancy cohort, 
(2) omitting important confounders associated with both smoking and preeclampsia, and (3) controlling 
for gestational age at delivery. 
In this article, we first used Direct Acyclic Grasps (DAGs) to illustrate the common bias structure. Next, 
we demonstrate how to correct for this selection bias using data from a case-control study nested within 
the Icelandic Medical Birth Register. 
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METHODS 
 
To evaluate the effect of the smoking-preeclampsia selection bias, we used data from a population-
based case-control study nested within all pregnancies in Iceland 1989-2004, resulting in birth at the 
Landspitali University Hospital.22 That study aimed to investigate the combined effects of obesity and 
smoking on hypertensive disorders during pregnancy. Any case of hypertensive disorder during 
pregnancy was selected retrospectively from the electronic National Medical Birth Registry based on 
the International Classification of Disease, 10th Revision [ICD-10]23 codes, O10-16.  
For the present study, we defined preeclampsia as any case of pregnancy induced hypertension (O13, 
O16) or preeclampsia (O14, O15, O11) occurring after 20 weeks’ gestation. We excluded cases of 
preexisting hypertension (O10) and restricted the analysis to women with only one singleton pregnancy. 
The final dataset contained 376 preeclampsia prevalent cases matched on year of delivery to 933 
normotensive mothers (N = 1,382) (Figure 1).  
We included the following variables: maternal age at delivery, early pregnancy BMI, parity, gestational 
age at delivery, smoking during pregnancy, and preeclampsia status. Weight (kg) and height (m) were 
measured at the first prenatal visit, which occurred on average at pregnancy week 13 (median: 13.8, 
interquartile range: 12.0-15.3).  Early pregnancy BMI was categorized according to international 
standards as kg/m2: underweight (BMI <18.5), normal weight (BMI <18.5-24.9), overweight (BMI 25.0-
29.9), obese (BMI ≥30.0). We merged underweight and normal weight given the reduced number of 
underweight women (n= 22) in analysis. We dichotomized maternal age into ≥35 years vs. <35, parity 
into multiparous (≥2 previous deliveries) and nulliparous (first delivery) women, and gestational age at 
delivery (preterm <37 weeks vs. term ≥37 weeks). Finally, maternal self-report of smoking during 
pregnancy was dichotomized (yes vs. no). Women who self-reported having quit smoking at the first 
prenatal visit were considered non-smokers (n= 37). Information on quantity or type of smoking was not 
available.  
Using DAGs we described the smoking-preeclampsia paradox, then we used a mediation analysis to 
explore the structure of the bias, and finally we developed both deterministic and probabilistic sensitivity 
analysis to estimate the amount of bias and corrected for it.21,24-27  
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Notations 
We employed notations of counterfactuals.28 We denoted A our exposure of interest (e.g., maternal 
smoking status during pregnancy), M represented the mediator (e.g., preterm delivery, <37 gestation 
weeks) and Y represented the primary outcome of interest (e.g., preeclampsia). We used C to denote 
some set of baseline characteristics measured before or concurrent with the exposure A, and U some 
unmeasured confounders (e.g., miscarriage, fetal death, fetoplacental pathologies associated with 
preterm delivery, etc.). Finally, we used Ya to denote the counterfactual outcome for each individual if 
the exposure had been set to level a and Ma denoted the intermediate if the exposure had been set to 
level a.  
For statistical analyses we used Stata v.13.1 (Statacorp, College Station, Texas, U.S.) and the user 
written macro “paramed”.29,30 
RESULTS 
Structure of the paradox: simulated scenarios 
Case-control studies nested within a birth cohort, with a density incidence sampling design and incident 
cases, require precise information regarding the onset time of both exposure and outcome. Accurate 
information regarding time is needed to prevent that the start of follow-up and the end of the study 
coincide (Figure 2).31,32 Neglecting this principle is the source of the occurrence of incidence-prevalence 
biases in cases-control studies nested within a birth cohort.13,31,32,33 The use of prevalent cases in case-
control studies makes it impossible to account for the association between the onset time of 
preeclampsia and any other measured and unmeasured factors that avert the development of 
preeclampsia (e.g., fetoplacental pathologies associated with preterm delivery).  
Using recent preeclampsia incidence estimates by gestation week published elsewhere,34 we sought 
to depict in a simple figure the smoking preeclampsia paradox (Figure 2). Figure 2 shows a simulated 
scenario of the smoking-preeclampsia paradox. The curve represents preeclampsia incidence rates by 
gestation weeks and dashed, and solid lines represent time to delivery for cigarette smokers (n = 5) 
and non-smokers (n= 5). In this example, preterm deliveries among smokers avert the further 
development of preeclampsia. However, depending on the type of study design and the use of prevalent 
or incident cases, the point estimated of the effect of smoking on preeclampsia varies from 0.4 to 1.05. 
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As shown in figure 2A, using a classical case-control study, without accounting for time, shows a 
protective association between maternal smoking and preeclampsia. Figure 2B depicts the scenario of 
a case-control study with a density sampling design. Under this scenario, the use of prevalent cases to 
account for person-time at risk also shows a protective association. The onset time of the outcome is 
not ascertained and the time at risk coincides with the duration of the gestation. Therefore, this 
represents conditioning implicitly on gestation weeks at delivery. Finally, figure 2C shows the inversion 
of the effect between maternal smoking and preeclampsia when the study design accounts for the 
correct estimate of person-time at risk using incident cases in a cohort study design where the onset 
time of the outcome is ascertained.  
Descriptive results with empirical data: presenting the paradox 
Women with preeclampsia were slightly older, more likely to be overweight and obese and to be 
nulliparous as compared with normotensive controls. The frequency of smoking among cases was lower 
(15% vs. 20%), and the odds of preeclampsia were reduced among smokers as compared with non-
smokers (odds ratio (OR) = 0.72, 95% confidence intervals (CI): 0.52, 0.99) (Table 1). Overall, smokers 
and non-smokers were similar with regards to maternal age, early pregnancy BMI, and parity (Table 2). 
DAGs and analytic results: unveiling the paradox 
 
Figure 3 depicts the structure of the classical epidemiologic approach to estimate unadjusted and 
adjusted total effect of smoking (A) on preeclampsia (Y) using logistic regression models. The effect of 
smoking on preeclampsia was estimated to be protective with a 28% reduction of odds among smokers 
compared with non-smoker women. Because we were attempting to estimate the effect of maternal 
smoking exposure on the risk of preeclampsia by using prevalent cases, we were conditioning implicitly 
on been born at “x” specific gestation weeks. This is an example of collider bias where conditioning on 
being born at “x” specific gestation weeks, U (placental pathology) becomes a confounder of the 
smoking-preeclampsia association and induces bias.  
Figure 4, describes the collider stratification effect that occurs after stratification by gestational age at 
delivery. The protective effect of maternal smoking (A) on the risk of preeclampsia increased among 
preterm infants (<37 gestation weeks) with 75% of odds reduction (adjusted OR = 0.25, 95%CI: 0.10, 
0.68). Stratification by term and preterm delivery status creates a new association between maternal 
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smoking (A) and unmeasured confounders (U) because maternal smoking and unmeasured 
confounders are both associated with preterm delivery and preeclampsia.  
To disentangle the multiple pathways that may explain the association of an exposure (A) on an 
outcome (Y), we applied a mediation analysis to assess the extent to which the effect of an exposure 
is explained, or is not, by an intermediate variable or mediator (M).35 Figure 5 depicts the scenario when 
smoking (A), for each woman would have two possible counterfactual outcomes, Y1 and Y0, 
corresponding to what would have happened to the woman (e.g. with or without smoking). Likewise, 
we had two possible counterfactual intermediates M1 (delivery before 37 gestation weeks) and M0 
(delivery after 37 gestation weeks). For each woman, we were able to observe only one of Y1 or Y0 
corresponding to the exposure that was in fact received; and likewise for M1 and M0. The mediation 
analysis showed the structure of the bias, assuming the presence of unmeasured confounders (i.e. 
placental pathology) for the mediator-outcome relationship (i.e. preterm delivery and preeclampsia). 
According to the causal graph theory, conditioning on the mediator M (i.e. preterm delivery) induces a 
spurious association between the mediator-outcome confounder U (i.e. placental pathology) and the 
exposure A (maternal smoking), and induces bias. Therefore, the estimated total effect of (A) on (Y) is 
biased (Figure 5).9 
In the mediation analysis, we defined the natural indirect effect (NIE) as the contrast between the 
counterfactual outcome when the exposure is fixed at A = 1 (smoking) comparing the effects if the 
distribution of the mediator were set to what it would have been with preterm versus term delivery 
(Y1,M(1) - Y1,M(0)). Intuitively, the natural indirect effect captures the effect of the exposure. Thus, if 
smoking positively affects the mediator (M) and the supposed mediator-outcome confounder (U) is 
positively associated with both the outcome and the mediator, the direct effect for a given level of M is 
likely to be biased downwards, corresponding to an apparent inverse direct effect of maternal smoking 
on preeclampsia.9,35  
Figure 5 reveals how the direct effect is biased downwards showing an apparent protective effect. 
However, in contrast, to classical and stratified analyses (Figures 3 and 4), the NIE in our empirical 
example showed an OR >1 for the association between maternal smoking and preeclampsia mediated 
by preterm delivery, thereby revealing the structure of the bias. 
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Sensitivity analysis 
Finally, to address this bias, we developed a sensitivity analysis to assess how such an unmeasured 
common cause (U) of the intermediate (M) and the outcome (Y) might affect the total effect 
estimated.26,27,36  
Let γ denote the odds of preeclampsia (Y) comparing U = 1 and U = 0 conditional on smoking exposure 
(A), preterm delivery (M), and let πam denote the prevalence of U among those with smoking status a 
=1 (smokers) or a = 0 (non-smokers) and prematurity status m (m = 1 or m = 0). If U is associated with 
preeclampsia (Y) by the same factor that it is associated with preterm and term deliveries, then the ratio 
between the estimate not controlling for U and the estimate that would have been obtained after 
controlling for U is given by:26 
 (1) 
The bias-adjusted OR (that would have been obtained when adjusting for U) could be estimated by 
dividing the estimated odds ratio by the bias factor B.52 For our sensitivity analysis we used fetal death 
as a surrogate of placental pathology. Fetal deaths among smokers are 1 to 4 times higher than among 
non-smokers37,38 and odds ratios for the association between placental pathology with fetal death and 
preeclampsia ranges between 2 and 86.34 
We fixed the prevalence of U (i.e., fetal death) for smokers with preeclampsia to π1m = 0.08 and π0m = 
0.30 for non-smokers (RR = 3.7). We based our choice on previous evidence regarding the association 
between fetal deaths and maternal smoking (three times higher among smokers).39,40  We fixed π0m = 
0.30, because if smoking were not the cause of fetal death, this renders some other explanation more 
likely, such as fetal malformations, maternal medical conditions, placental pathology.9  
In the empirical example, we have shown that the odds of preeclampsia were reduced among smokers 
as compared with non-smokers (OR = 0.72 95%CI: 0.52, 0.99). However, if the association between Y 
(preeclampsia) and U (i.e., fetal death) were a 3.5-fold increase (γ = 3.5),34 we would have had a bias 
factor B in equation (1) of 0.69. Hence, the bias-adjusted OR for the association between preeclampsia 
and maternal smoking showed a positive association (Bias-adjusted OR = 0.72/0.69 = 1.05, 95%CI: 
0.50, 2.00) (Table 3).  
0m
1m
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1)-(1
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Table 3 shows the result of bias-adjusted OR for different deterministic simulated scenarios. 
Furthermore, based on equation (1) we developed a probabilistic sensitivity analysis using Monte 
Carlo41 simulations (10,000 replications) to bias adjust different OR estimates for values of π1m ranging 
between 0.01 and 0.08, π0m between 0.01 and 0.30, and γ (effect of U on Y) between 1 and 5.5. Based 
on these assumptions the probabilistic bias-adjusted OR was 1.22, (95%CI:  0.41, 6.53). 
DISCUSSION 
 
Using DAGs and mediation causal analyses we unveiled the structure and influence of selection bias 
(namely collider bias) on the association between maternal smoking during pregnancy and 
preeclampsia risk. Furthermore, we showed how potential unmeasured confounders may distort the 
analyses that condition on gestational age at birth. Finally, using a sensitivity analysis to address this 
bias, we showed how the inverse association of smoking on preeclampsia shifted from 28% risk 
reduction to a non-significant bias-adjusted effect of 22% risk increase of preeclampsia for smokers as 
compared with non-smokers.  
The etiology of preeclampsia is not well understood, but several risk factors have been identified such 
as genetic factors,42,43 nulliparity, multifetal gestations, maternal race, age, and pre-existing conditions 
such as pre-gestational hypertension, diabetes, kidney disease, obesity, and a prior history of 
preeclampsia.44  However, even if smoking during pregnancy is recognized as the most important 
preventable risk factor for many adverse pregnancy and perinatal outcomes,45-49  some authors have 
presented a paradoxical protective effect of smoking on preeclampsia.3,4,7,16-20,50 The paradoxical risk 
reduction ranges from 10% to 50%7 and an inverse dose-response relationship has also been 
reported.50  
Overwhelming evidence supports the conclusion that cigarette smoking causes various adverse 
cardiovascular events including hypertension.51-53 However, several underlying biological mechanism 
for the protective smoking effect on preeclampsia have been hypothesized (i.e., carbon monoxide-
mediated inhibition of inflammation,54,55 enhanced vasodilation,56 suppression of platelet aggregation,57 
plasminogen activation,54,58 apoptosis,59 antiangiogenic factor60,61 and, soluble fms-like tyrosine kinase-
155,61). These mechanisms remain poorly understood and are based on observational data with 
inconsistent evidence of questionable causal interpretation.7,50  
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Furthermore, establishing a clear biologic mechanism to explain the smoking-preeclampsia paradox 
has been complicated by the observation that active maternal smoking is also strongly associated with 
increased risk of perinatal conditions that end the pregnancy prematurely, such as fetal death and 
fetoplacental pathology associated with preterm or elary term delivery.62-64 Thus, the premature end of 
the pregnancy avert further preeclampsia development.   
To appreciate the statistical artifact that promotes this important perinatal epidemiological smoking-
preeclampsia paradox, we invite readers to consider an example in cardiovascular epidemiology.13 
Suppose that a case-control study is carried out to investigate the relation between smoking and acute 
myocardial infarction (AMI), with cases interviewed one week after the coronary attack (prevalent 
cases). If AMI patients who are smokers die more frequently than AMI patients who are non-smokers, 
the analyses of surviving AMI cases will show a lower frequency of smoking, underestimating the true 
association of smoking with incident AMI.12,13 The same holds for the smoking-preeclampsia paradox, 
where smoking is associated with miscarriage, fetal death and preterm delivery. It follows that pregnant 
women who are smokers and who experience higher risks of conditions related to early pregnancy 
termination cannot then have their pregnancies complicated by preeclampsia.8  
The majority of the evidence supporting the protective effect of smoking on preeclampsia is based on 
prevalent cases assessed at birth.3,4,7,16-20,50 An important consideration in designing a case-control 
study is whether or not it is possible to include incident or prevalent cases (i.e., prevalent cases of 
preeclampsia are ascertained at birth among the pregnancies that have survived from the time of its 
conception until birth).65 The inability to fully account for outcomes of all conceptions because of the 
attrition of pregnancies, may lead to selection bias.9,21,31,32 
Furthermore, in case-control studies with prevalent cases nested within a birth cohort, the selection of 
controls is dependent on the exposure (i.e., maternal smoking) when the exposure is associated with 
prematurity).66-69 It is explained because the probability of selecting non-preterm controls is higher than 
the probability of selection preterm controls since  preterm deliveries are less frequent than term 
deliveries. In addition, the duration of the pregnancy is considered the period at risk for developing 
preeclampsia. Thus, women who deliver at term have a higher probability of being selected as controls 
(over-represented because of longer duration of the gestation).66-69 Hence, as our findings suggest, the 
exposure distribution among controls is not an estimate of the exposure distribution in the person-time 
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that gave rise to the cases over-representing non-preterm infants from both smokers and non-smokers 
women. On the other hand, when using prevalent cases the start of the follow-up and the end of the 
study coincides, time is not accounted correctly and may lead to an over-representation of exposed 
cases of long duration (i.e., smokers with preeclampsia delivering at term).31-33,69 Thus, the sampling 
will be biased because the probability of selection at a given point in time depends on the time spent at 
risk.66,69 
Given the observational nature of epidemiological research, paradoxical associations may arise when 
complex relations between risk factors and outcomes are modeled without considering the limitations 
of different study designs and the complex effect of time.31,32,65-67 Causal inference and mediation 
analysis help to understand and disentangle epidemiological paradoxes such as the example illustrated 
in our present study.  
Different methodological approaches have been suggested to unveil paradoxical effects in perinatal 
epidemiology.8-10,12,70 The use of DAGs helps to clarify the structure of the biases, and distinguishes 
between biases resulting from (inappropriate) conditioning on common effects (collider bias) and lack 
of conditioning on common causes of exposure and outcome (confounding).9,11,21,71 However, 
conditioning on an intermediate with sensitivity analysis has been described as the approach of greatest 
interest in perinatal epidemiology.9 The advantage of this approach is that, after correction of the bias 
through sensitivity analysis, the effect of the exposure for individuals with the intermediate, correspond 
to the direct effect of the exposure on the outcome not through the intermediate.9 
We used both, deterministic and probabilistic sensitivity analyses, to bias adjust the association 
between maternal smoking and preeclampsia. Deterministic sensitivity analysis provides an external 
adjustment of the observed measure of association upon the specification of a list of hypothetical values 
for the bias parameters without accounting for the uncertainty of the bias parameters.41,73  Therefore, 
we used a probabilistic sensitivity analysis to overcome this limitation specifying prior probability 
distributions for the bias parameters that capture our uncertainty about the bias parameters.41 On the 
other hand, the probabilistic approach requires estipulate deterministic prior distributions about the bias 
parameters24,25,73 and this has been criticized because it reflects judgments of the investigator about 
sources of systematic error and therefore subjectivity (by varying the input prior distributions for 
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probabilistic sensitivity analyses).73 However, to minimize subjectivity we used published evidence to 
support this uncertainty.37,38  
Future observational case controls studies may have to consider the use incident cases and matching 
with controls by time (i.e. gestation weeks at delivery) in a density sampling design. In case this is not 
feasible, the smoking-preeclampsia paradox will have to be addressed considering the effect of 
potential unmeasured confounders between intermediates (gestation weeks) and outcome 
(preeclampsia), through a sensitivity analysis. Alternatively, in the case of longitudinal studies, 
investigators should consider conditioning on measured potential confounders, establishing the start of 
follow-up at a given specific gestation week, the closest to the conception of the gestation the better. 
Furthermore, to deal with the smoking-preeclampsia paradox, researchers will need to account for the 
exact onset time of preeclampsia in order to estimate precise person time at risk and finally, if available 
data, assessing smoking characteristics such us onset age, intensity and, duration. 
However, using data from vital statistics the assessment of some potential confounders is not possible 
given that some pregnancies will not have been selected into the population in study because they were 
left truncated.74 This situation will require other methodological approaches in the setting of longitudinal 
data analyses, such as accounting for competing risk for preeclampsia (e.g. miscarriages and very early 
pregnancy loss) preventing to develop the outcome under study.75 
In conclusion, using the counterfactual framework, DAGs and a probabilistic sensitivity analysis to 
evaluate bias due to an uncontrolled source of censoring preventing the outcome to develop we have 
unveiled the structure of the paradox in the setting of a case-control observational study. In particular, 
we have shown that the smoking-preeclampsia paradox is likely an example of selection bias most 
likely caused by studying cases prevalent at birth rather than all incident cases in a conception or 
pregnancy cohort, omitting important confounders associated with both smoking and preeclampsia 
(preventing the outcome to develop), and controlling implicitly or explicitly for a collider (gestation weeks 
at delivery).  Future studies will have to account for this bias or, at least, consider it in the interpretation 
of findings and weigh it against incomplete evidence on potential biologic mechanisms for this 
association. We hope that this study will guide future efforts in this area and help estimate true effects 
of cigarette smoking on maternal and perinatal outcomes, including preeclampsia.  
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ANNEX (Stata syntax) 
1. Simulation of preeclampsia cumulative incidence distribution by gestation weeks 
set seed 12345 
gen pe=24*(1-rbeta(2,5))+15  
hist pe  
 
2. Classic logistic regression, stratification and mediation analysis 
*CLASSICAL APPROACH: collider bias 
 
logistic PE SMOKING 
logistic PE SMOKING BMI AGE 
logistic PE SMOKING PARITY BMI AGE 
 
*STRATIFICATION: collider stratification bias 
 
logistic PE SMOKING PARITY BMI AGE if PTD==1 
logistic PE SMOKING PARITY BMI AGE if PTD==0 
 
*MEDIATION: collider bias 
 
paramed PE, avar(SMOKING) mvar(PTD) cvars(AGE BMI PARITY) a0(0) a1(1) m(1) yreg(logistic) 
mreg(logistic) boot seed(1234) 
 
paramed PE, avar(SMOKING) mvar(PTD) cvars(AGE BMI PARITY) a0(0) a1(1) m(1) yreg(logistic) 
mreg(logistic) nointer boot seed(1234) 
 
3. Sensitivity analysis 
 cc PE SMOKING 
 
episensi 57 319 186 747, st(cc) reps(100)  nodots dpexp(uni(.01  .08)) dpunexp(uni(0.01 0.30)) 
drrcd(log-n(ln(20)+ln(2.2)/(2)  ln(20)-ln(2.2)/2*1.96)) sed(123) 
 
episensi 57 319 186 747, st(cc) reps(1000)  nodots dpexp(uni(.01  .08)) dpunexp(uni(0.01 0.30)) 
drrcd(log-n(ln(20)+ln(2.2)/(2)  ln(20)-ln(2.2)/2*1.96)) sed(123) 
 
episensi 57 319 186 747, st(cc) reps(10000)  nodots dpexp(uni(.01  .08)) dpunexp(uni(0.01 0.30)) 
drrcd(log-n(ln(20)+ln(2.2)/(2)  ln(20)-ln(2.2)/2*1.96)) sed(123) 
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FIGURES LEGENDS 
Figure 1. Flowchart of the sampling selection process, n= 1,309 
Figure 2. Simulation of preeclampsia incidence estimates by gestational age (weeks) at delivery and 
smoking status. 
Footnote Figure 2: 
The source of preeclampsia estimates by gestation weeks: Harmon QE, Huang L, Umbach DM, et al. Risk of fetal death with 
preeclampsia. Obstet Gynecol. 2015;125(3):628-635, In-house.  
Figure 3. DAGs: collider bias (unadjusted and adjusted preeclampsia odds ratios by maternal smoking 
status). 
Figure 4. DAGs: collider stratification scenario (preeclampsia adjusted odds ratios by maternal smoking 
status and stratified by gestation weeks at delivery).  
Figure 5. DAGs: mediation analysis scenario (natural direct and indirect mediated effects). 
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TABLES 
Table 1. Maternal BMI, age, parity and smoking status by preeclampsia status (cases), n= 1,309 (29% 
preeclampsia, n=376 women). 
Variables   N (%) 
Preeclampsia, n 
(%) 
Odds Ratio 
(95%CI) p-value* 
Maternal age (years)         0.418 
  <35 1087 (83) 308 (28) Ref.   
  ≥35 219 (17) 68 (31) 1.13 (0.81, 1.57)   
Parity         <0.001 
Nulliparous  602 (46) 228 (38) 2.29 (1.77, 2.94)   
 Multiparous 704 (54) 148 (21) Ref.   
Early pregnancy BMI in kg/m2       <0.001 
Normal weight (<18-24.9) 763 (60) 174 (23) Ref.   
Overweight (25-29.9) 323 (25) 106 (33) 1.65 (1.24, 2.20)   
Obese (≥30) 182 (15) 84 (46) 2.90 (2.07, 4.06)   
Pregnancy Smoking status       0.044 
Smoker 933 (71) 57 (15) 0.72 (0.52, 0.99)   
Non-smoker 376 (29) 186 (20) Ref.   
*Pearson Chi-square         
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Table 2. Smoking status by maternal BMI, age and parity, n= 1,309 (19% smokers, n= 243). 
Variables   N (%) Smokes, n (%) Odds Ratio (95%CI) p-value* 
Maternal age (years)    0.399 
 <35 1087 (83) 197 (18) Ref.  
 ≥35 219 (17) 45 (21) 1.13 (0.84, 1.53)  
Parity     0.726 
 Nulliparous  602 (46) 128 (18) 1.03 (0.88, 1.20)  
 Multiparous 704 (54) 114 (19) Ref.  
Early pregnancy BMI in kg/m2    0.632 
Normal weight (<18-24.9) 763 (60) 137 (18) Ref.  
Overweight (25-29.9) 323 (25) 66 (20) 1.17 (0.84, 1.62)  
Obese (≥30) 182 (15) 34 (19) 1.05 (0.69, 1.60)  
*Pearson Chi-square     
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Table 3. Preeclampsia simulated bias adjusted odds ratios and 95%CI for maternal smoking.  
 
π1m π0m  (Effect of U on Y) 
 
  Bias (B)   Bias Adjusted OR   LCI (2.5%)   UCI (97.5%) 
 
0.02 
 
0.15 
 
3.00 
 
0.80 
 
0.90 
 
0.58 
 
1.71 
0.02 0.15 3.50 0.76 0.94 0.55 1.80 
0.02 0.15 4.00 0.73 0.98 0.53 1.88 
0.02 0.15 4.50 0.70 1.03 0.51 1.95 
0.02 0.15 5.00 0.68 1.07 0.49 2.03 
0.02 0.15 5.50 0.65 1.11 0.47 2.11 
       
0.04 0.20 3.00 0.77 0.93 0.56 1.78 
0.04 0.20 3.50 0.73 0.98 0.53 1.87 
0.04 0.20 4.00 0.70 1.03 0.51 1.96 
0.04 0.20 4.50 0.67 1.07 0.48 2.04 
0.04 0.20 5.00 0.64 1.12 0.47 2.13 
0.04 0.20 5.50 0.62 1.16 0.45 2.21 
       
0.08 0.30 3.00 0.73 0.99 0.52 1.89 
0.08 0.30 3.50 0.69 1.05 0.50 2.00 
0.08 0.30 4.00 0.65 1.10 0.47 2.10 
0.08 0.30 4.50 0.62 1.15 0.45 2.20 
0.08 0.30 5.00 0.60 1.20 0.43 2.28 
0.08 0.30 5.50 0.58 1.24 0.42 2.37 
         
π1m: Unobserved confounders for smoking mothers; π0m: Unobserved confounders for non-smoking mothers; 
: Effect of U on preeclampsia; OR: Odds Ratio; LCI: Lower confidence interval; UCI: Upper confidence interval 
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A: Smoking 
  M: Gestation 
weeks at delivery   Y: Pre-eclampsia* 
U1: Placental pathology 
AOR: 0.68, 95%CI(0.48, 0.95) 
C1: Maternal BMI 
  C2: Parity 
C3: Maternal Age  
Classical approach (case control study with prevalent cases): 
E(Y|A) = log(OR) = β0 + β1Smoking 
OR: 0.72, 95%CI(0.52, 0.99) 
E(Y|A,C) = log(OR) = β0 + β1Smoking + β3BMI + β3AGE + β4Parity   
*Prevalent pre-eclampsia  
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A: Smoking 
 m1: Preterm  
delivery 
   
Y: Pre-eclampsia* 
C1: Maternal BMI 
  
AOR: 0.25, 95%CI(0.10, 0.68) 
 C2: Parity 
C3: Maternal Age  
Classical approach (case control study): Stratification and collider effect 
E(Y|A,C m0) = log(OR) = β0 + β1Smoking + β3BMI + β3AGE + β4Parity   
  m0:Term delivery 
   
E(Y|A,C m1) = log(OR) = β0 + β1Smoking + β3BMI + β3AGE + β4Parity   
AOR: 0.75, 95%CI(0.51, 1.10) 
 *Prevalent pre-eclampsia  
  assessed after delivery 
U1: Placental pathology 
A: Smoking M: Preterm delivery Y: Pre-eclampsia 
C or U*: 
Placental pathology 
*Measured or unmeasured confounder 
 
 
C: Confounders: 
 Maternal BMI 
 Maternal Age  
 Parity 
Marginal Total Effect: 0.68, 95%CI(0.45, 0.97) Mediation analysis: 
Assumptions: 
(1) is Yam ∐  A|C 
(2) is Yam ∐ M|C,A 
(3) is  Ma ∐  A|C 
(4) is Yam ∐ Ma*|C 
NIE: 1.05, 95%CI(0.92, 1.20) 
 
NDE: 0.65, 95%CI(0.44, 0.92) 
*Prevalent pre-eclampsia  
  assessed after delivery 
